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Introduction
Enthestis related arthritis (era) represent an undifferen-
tiated form of spondyloarthritis (spa), distinguishing it
from other subtypes of JIA for optimum treatment and
outcome, as well as for studies aimed at understanding
genetic predisposition and pathogenesis. Majority of these
studies focused on genome associations within MHC, only
few searched for connections outside of this region and
only some analyzed transcriptome of era patients. Our
preliminary results of gene expression profiling in PBMC
of 11 new onset and untreated patients diagnosed with
era, identified 744 differentially expressed genes.
Objectives
To validate results of gene expression analysis in groups
of patients diagnosed with era and other subtypes of JIA.
Methods
Based on extensive and diligent statistical analysis,
ten genes (CXCR4, NLRP3, PTPRN2, TLR4, DUSP6,
MAP2K2, MAPKBP1, MYST3, PTPN12, TNFSF4) were
selected for further RT-PCR analysis in four groups of
patients selected according to ILAR criteria (N = 56):
untreated era patients with obtained expression profile
(P1 = 11; 1 B7, 2 B27, 8 B7/B27), untreated era patients
(P2 = 10; 2 B7, 6 B27), treated era patients (P3 = 24; 5 B7,
12 B27, 1 B7/B27) and treated JIA patients (P4 = 11). All
groups were compared to healthy controls (N = 12). For
all era patients HLA typing was preformed.
Results
Statistically significant (p < 0.05) fold change (FC) was
shown for CXCR4 (FC 1.89), TLR4 (FC 4.36), MAPKBP1
(FC -3.13) and PTPN12 (FC -3.70) in P1 group, CXCR4
(FC 1.87), NLRP3 (FC -5), PTPRN2 (FC -5.55), TLR4 (FC
3.91) and PTPN12 (FC -2.63) in P2 group, CXCR4 (FC
1.37), NLRP3 (FC -3.71), MAPKBP1 (FC -1.82), PTPN12
(FC -2.44) and TNFSF4 (FC -1.52) in P3 group and
PTPN12 (FC -5) in P4 group.
Conclusion
Majority of genes with significant FC had a role in NF-b
and MAPK pathways, which are important for regulation
of immune response. TLR-4 is known activator of inflam-
matory cascade that involves NLRP3, and is responsible for
secretion of proinflammatory cytokines, while PTPN12
negatively regulates TLR-triggered innate response and
lymphocyte activation. Hence, lower expression of PTPN12
can boost immune response. CXCR4 triggers MAPK sig-
naling in response to LPS, and recruits inflammatory cells.
CXCR4 showed higher expression in all groups of era
patients, regardless of treatment, and PTPN12 showed
lower expression even in group of other JIA patients, which
could indicate an important role of these genes in patho-
genesis of era and other JIA subtypes. TLR4 showed higher
expression in untreated era patients, suggesting that stan-
dard treatment could influence this gene expression. Inter-
estingly, NLRP3 showed lower expression in group of
treated and untreated patients with era. Polymorphisms of
NLRP3 that causes decreased gene expression and IL-1b
production were linked with increased susceptibility to
Chron’s disease, while polymorphisms of PTPN12 gene
were identified in autoinflammatory diseases. Further on,
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oncology studies showed PTPN12 gene could be silenced
by methylation. Precise mechanism responsible for lower
expression of these genes in era and other JIA patients still
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